Literature DB >> 1562678

Infection with Mycobacterium haemophilum.

P Becherer, R L Hopfer.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1562678     DOI: 10.1093/clinids/14.3.793

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

Review 1.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 2.  Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.

Authors:  M A Saubolle; T E Kiehn; M H White; M F Rudinsky; D Armstrong
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Lesser known mycobacteria.

Authors:  B Watt
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

Review 4.  Mycobacterium haemophilum: an emerging pathogen.

Authors:  T E Kiehn; M White
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

5.  DNA polymorphisms detected in Mycobacterium haemophilum by pulsed-field gel electrophoresis.

Authors:  M A Yakrus; W L Straus
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

6.  Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum.

Authors:  K Kikuchi; E M Bernard; T E Kiehn; D Armstrong; L W Riley
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Biochemical properties and fatty acid composition of Mycobacterium haemophilum: study of 16 isolates from Australian patients.

Authors:  F Portaels; D J Dawson; L Larsson; L Rigouts
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

8.  Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum.

Authors:  E M Bernard; F F Edwards; T E Kiehn; S T Brown; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.